EUVIMEDEUVIMED entdecken
Crossref

[ 68 Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake

Haiyan Hong iD, Zhihao Zha, Ruiyue Zhao, Yang Luo, Wenbin Jin, Linlin Li, Ran Wang, Li Yan, Hui Wang, Karl Ploessl iD, Jinping Qiao, Lin Zhu und 1 weitere

Molecular Pharmaceutics · 2023

DOI: 10.1021/acs.molpharmaceut.2c01112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Haiyan Hong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, P. R. China. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Positron-Emission Tomography. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Five Eleven Pharma Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesPositron-Emission TomographyAnimalsMiceMice, NudeCell Line, TumorChelating AgentsPositron Emission Tomography Computed TomographyEdetic Acid

Stichwörter der Autor:innen

PET/CTfibroblast activation proteinradiopharmaceuticalstumor binding affinitytumor imaging

Substanzen

Gallium RadioisotopesChelating AgentsN,N'-bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine N,N'-diacetic acidEdetic Acid

Autor:innen und Institutionen

  • Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, P. R. China.
  • Five Eleven Pharma Inc., Philadelphia, Pennsylvania 19104, United States.
  • Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.

ORCID-Profile: Haiyan Hong, Karl Ploessl, Hank F Kung

Förderung

  • Five Eleven Pharma Inc.

Zitieren

APA

Hong, H., Zha, Z., Zhao, R., Luo, Y., Jin, W., Li, L., Wang, R., Yan, L., Wang, H., Ploessl, K., Qiao, J., Zhu, L., & Kung, H. F. (2023). [ 68 Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c01112

Vancouver

Hong H, Zha Z, Zhao R, Luo Y, Jin W, Li L, et al. [ 68 Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c01112

BibTeX
@article{Hong2023,
  author = {Hong, Haiyan and Zha, Zhihao and Zhao, Ruiyue and Luo, Yang and Jin, Wenbin and Li, Linlin and Wang, Ran and Yan, Li and Wang, Hui and Ploessl, Karl and Qiao, Jinping and Zhu, Lin and Kung, Hank F},
  title = {[ 68 Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  doi = {10.1021/acs.molpharmaceut.2c01112}
}
Kostenlos starten →